'Dose-Sparing' Flu Vaccine Could Boost Productivity and Vaccine Availability
The currently licensed seasonal trivalent influenza vaccines contain 15 micrograms of viral hemagglutinin protein per strain for adults, and up to 60 micrograms for elderly individuals; however, due to recent shortages, reducing these doses would be highly desirable. A recent study has found that significant dose sparing is possible with the use of whole virion vaccines and aluminium adjuvants, without compromising safety.
Whole virion vaccines contain whole virus, not just hemagglutinin as in most human flu vaccines. Adjuvants are added to help create a stronger immune response in the patient's body.
"Based on our results, a new, reduced dose seasonal vaccine is being licensed in the European Union member state in Hungary, which will impact production capacities and ultimately, vaccine availability to patients," wrote the authors of the British Journal of Clinical Pharmacology study.
Source: Wiley
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
Happy Hand Hygiene Day! Rethinking Glove Use for Safer, Cleaner, and More Ethical Health Care
May 5th 2025Despite their protective role, gloves are often misused in health care settings—undermining hand hygiene, risking patient safety, and worsening environmental impact. Alexandra Peters, PhD, points out that this misuse deserves urgent attention, especially today, World Hand Hygiene Day.
